PROGRESSIVENESS AND GENERALIZABILITY OF THE EFFECTS OF ALENDRONATE ON BONE MASS AND SAFETY EXPERIENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

被引：0
|
作者：
EMKEY, R
CORREAROTTER, R
SANTORA, A
LOMBARDI, A
DAIFOTIS, A
机构：
[1] READING MED CTR,BONE RES CTR,W READING,PA 19610
[2] NATL INST NUTR,MEXICO CITY,DF,MEXICO
[3] MERCK & CO INC,MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065
来源：
ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1239 / 1239
页数：1
相关论文
共 50 条
  • [1] 3-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH ORAL ALENDRONATE - EFFECTS ON BONE MASS AND TURNOVER AND SAFETY
    DOWNS, R
    BAKER, M
    BELL, N
    EMKEY, R
    TONINO, R
    TUCCI, J
    WEISS, S
    PEVERLY, C
    KHER, U
    SANTORA, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S139 - S139
  • [2] Five-year treatment of osteoporosis in postmenopausal women with oral alendronate: Effects on bone mass and turnover and safety
    Favus, M
    Emkey, R
    Leite, M
    Devogelaer, JP
    Rodriguez, J
    Peverly, C
    Kaur, A
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : 189 - 189
  • [3] The effects of oral alendronate on bone mass and turnover and safety: Five-year treatment of osteoporosis in postmenopausal women.
    Emkey, R
    McIlwain, H
    Favus, M
    Leite, M
    Devogelaer, JP
    Rodriguez, J
    Peverly, C
    Arnold, A
    Kaur, A
    Santora, A
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 626 - 626
  • [4] Differential effects of teriparatide and alendronate on bone parameters in postmenopausal women with osteoporosis
    McClung, MR
    Martin, JS
    Meunier, PJ
    Miller, PD
    Haddock, L
    Bandeira, F
    Szejnfled, V
    Donley, DW
    Eriksen, EF
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S5 - S5
  • [5] Ten years' experience with alendronate for osteoporosis in postmenopausal women
    Bone, HG
    Hosking, D
    Devogelaer, J
    Tucci, JR
    Emkey, RD
    Tonino, RP
    Rodriguez-Portales, JA
    Downs, RW
    Gupta, J
    Santora, AC
    Liberman, UA
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12): : 1189 - 1199
  • [6] SUPERIOR EFFECTS OF STRONTIUM RANELATE COMPARED TO ALENDRONATE ON BONE MASS AND STRENGTH PARAMETERS AT THE TIBIA IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Felsenberg, Dieter
    Brandi, Maria Luisa
    Sergi, Giuseppe
    Bergstrom, Ingrid
    Beller, Gisela
    Fiore, Carmelo
    Lyritis, George
    Kindmark, Andreas
    Boerst, Hendrikje
    Bock, Oliver
    Hartard, Manfred
    Runge, Martin
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 102 - 102
  • [7] Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis
    Iwamoto, Jun
    Sato, Yoshihiro
    Uzawa, Mitsuyoshi
    Takeda, Tsuyoshi
    Matsumoto, Hideo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 201 - 206
  • [8] Effects of raloxifene and alendronate on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis
    Johnell, O
    Lu, Y
    Seeman, E
    Reginster, J
    Scheele, W
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S184 - S184
  • [9] 10 YEARS OF EXPERIENCE WITH ALENDRONATE IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
    Pietschmann, Peter
    JOURNAL FUR MINERALSTOFFWECHSEL, 2007, 14 (03): : 124 - 126
  • [10] Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
    Finkelstein, Joel S.
    Wyland, Jason J.
    Lee, Hang
    Neer, Robert M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (04): : 1838 - 1845
12345